Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT00005639What this trial is testingAzacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous TreatmentWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Very early researchEnded earlyNCT04034446What this trial is testingCD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)Who this might be right forRelapsed or Refractory B Cell Acute Lymphoblastic Leukemia Institute of Hematology & Blood Diseases Hospital, China 2
Early research (Phase 1)Study completedNCT00005988What this trial is testingBone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous TherapyWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Ended earlyNCT00295880What this trial is testingDonor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+1 more Masonic Cancer Center, University of Minnesota 12
Large-scale testing (Phase 3)Study completedNCT00265837What this trial is testingLaboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Not applicableEnded earlyNCT00952185What this trial is testingInfluenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more City of Hope Medical Center 9
Not applicableStudy completedNCT00547196What this trial is testingAlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & DisordersWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes City of Hope Medical Center 10
Early research (Phase 1)Study completedNCT00002980What this trial is testingDecitabine in Treating Patients With Melanoma or Other Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more California Cancer Consortium
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Very early researchLooking for participantsNCT06890494What this trial is testingClinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell LeukemiaWho this might be right forLeukemia Beijing GoBroad Hospital 3
Testing effectiveness (Phase 2)Study completedNCT02000427What this trial is testingBlinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic LeukemiaWho this might be right forRelapsed/Refractory Philadelphia Positive B-precursor ALL Amgen 45
Testing effectiveness (Phase 2)Study completedNCT00002941What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's LymphomaWho this might be right forLymphoma Children's Oncology Group 69
Large-scale testing (Phase 3)Looking for participantsNCT07570173What this trial is testingA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)Who this might be right forB-cell Acute Lymphoblastic Leukemia Merck Sharp & Dohme LLC 340
Not applicableStudy completedNCT00005881What this trial is testingQuality of Life in Children Treated for CancerWho this might be right forLeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific Children's Oncology Group 538
Early research (Phase 1)Looking for participantsNCT06287528What this trial is testing19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)Who this might be right forPhiladelphia-Negative ALLPhiladelphia-Positive ALLRelapsed ALL, Adult+3 more Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)WithdrawnNCT03851081What this trial is testingInotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic LeukemiaWho this might be right forAllogeneic Hematopoietic Stem Cell Transplantation RecipientBlasts 5 Percent or More of Bone Marrow Nucleated CellsBlasts 5 Percent or More of Peripheral Blood White Cells+5 more Roswell Park Cancer Institute
Early research (Phase 1)UnknownNCT03599375What this trial is testingImmunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic LeukemiaWho this might be right forLeukemia, B-Cell jiuwei cui 20
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12